Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,576 public trials 831 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Active, Not Recruiting

Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma

NCT05123131

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Aarhus University Hospital Aarhus, Denmark
  • Beaumont Hospital Dublin, Ireland
  • Mater Misericordiae University Hospital Dublin, Ireland
  • St James's Hospital Dublin, Ireland
View Trial Details
Active, Not Recruiting

Multiple Myeloma Molecular Monitoring Study

NCT03421132

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • CancerCare Manitoba Winnipeg, Manitoba, Canada
View Trial Details
Active, Not Recruiting

A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

NCT04458831

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Arkansas Medical Sciences Site Number : 8400021 Little Rock, Arkansas, United States
  • St. Joseph Heritage Healthcare Site Number : 8400008 Fullerton, California, United States
  • University of California San Francisco (PARENT) Site Number : 8400009 San Francisco, California, United States
  • Holy Cross Hospital Site Number : 8400030 Fort Lauderdale, Florida, United States
View all 129 locations
View Trial Details
Active, Not Recruiting

A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

NCT03539744

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Duplicate_University of Arizona Cancer Center - North Campus /ID# 218407 Tucson, Arizona, United States
  • VA Central California Health Care System /ID# 200047 Fresno, California, United States
  • University of California, Los Angeles /ID# 171524 Los Angeles, California, United States
  • Rocky Mountain Regional VA Medical Center/Eastern Colorado Health Care System /ID# 222904 Aurora, Colorado, United States
View all 180 locations
View Trial Details
Active, Not Recruiting

Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia

NCT05325593

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • IRCCS AOU di Bologna, Seràgnoli Institute of Hematology Bologna, Italy
  • ASST Fatebenefratelli Sacco - Ospedale L. Sacco Milan, Italy
  • Grande Ospedale Metropolitano Niguarda Milan, Italy
  • Azienda Ospedaliero-Universitaria Policlinico Umberto I / SAPIENZA Universitá di Roma Rome, Italy
View all 30 locations
View Trial Details
Active, Not Recruiting

Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma

NCT03190525

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI Ancona, Italy
  • S. Orsola Malpighi Bologna, Italy
  • Divisione di Ematologia Ospedale A. Perrino Brindisi, Italy
  • ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO Cagliari, Italy
View all 35 locations
View Trial Details
Active, Not Recruiting

The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia

NCT02577926

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Universitätsmedizin Mannheim III. Medizinische Klinik Hämatologie und Internistische Onkologie Mannheim, Baden-Wurttemberg, Germany
  • Universitätsklinikum Ulm Klinik für Innere Medizin III Ulm, Baden-Wurttemberg, Germany
  • Rems-Murr Klinikum Winnenden Winnenden, Baden-Wurttemberg, Germany
  • Studienzentrum Aschaffenburg Aschaffenburg, Bavaria, Germany
View all 23 locations
View Trial Details
Active, Not Recruiting

Study of 3D189 in Patients With Hematologic Malignancies

NCT05320809

Conditions
Acute Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • The First Affiliated Hospital Of Nanchang University Nanchang, Jiangxi, China
  • Shengjing Hospital of China Medical Shengyang, Liaoning, China
  • Blood Disease Hospital , Chinese Academy of Medical Science Tianjing, China
View Trial Details

Related conditions